CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Synbiotics Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Synbiotics Corporation
12200 NW Ambassador Drive
Suite 101
Phone: 816-464-3500p:816-464-3500 Kansas City, MO  64163  United States Ticker: SYNBSYNB

This company was Merged or Acquired on 12/30/2010.
This company ceased filing statements with the SEC on 11/3/2005.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Synbiotics Corporation is a provider of rapid diagnostic and laboratory diagnostic products for the animal healthcare industry. The Company's product portfolio consists of 96 diagnostic test kits and detection devices. Synbiotics Corporation provides rapid diagnostic and laboratory diagnostic products for the animal healthcare industry. Synbiotics' product portfolio consists of 93 diagnostic test kits and detection devices. The Company sells its products globally to veterinary practices, laboratories and poultry producers in the United States, Canada, Europe, Africa, Oceania, Asia and Latin America. Its canine heartworm diagnostics represented 24% of total net sales in the year ended December 31, 2004.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200512/31/2004YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director Paul R.Hays 44 2/1/2005 12/1/2002
Chief Financial Officer, Vice President-Finance, Secretary Keith A.Butler 43 9/1/2002 3/1/1991
Vice President-Operations CliffordFrank 55 9/1/2002 9/1/2002
4 additional Officers and Directors records available in full report.

Business Names
Business Name
SYNB
Synbiotics Corp.
Synbiotics Europe SAS

General Information
Number of Employees: 93 (As of 12/31/2004)
Outstanding Shares: 33,822,033 (As of 8/15/2005)
Shareholders: 567
Stock Exchange: OTC
Federal Tax Id: 953737816
Fax Number: 816-464-3521
Email Address: info@synbiotic.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023